DIP Episode 208 - Transfusion Reactions
Topic
Transfusion reactions; Acute Hemolytic Transfusion Reaction (AHTR); Delayed Hemolytic Transfusion Reaction; Allergic reaction...
Key Takeaway
Transfusion reactions are diverse, ranging from Type I (Allergic) and Type II (Hemolytic) hypersensitivity to complex immune-mediated syndromes like TRALI and TAGVHD, requiring careful differentiation based on timing, mechanism, and hemodynamic status.
Episode Notes
Source / episode info
- Episode: 208
- Title: Divine Intervention Episode 208 – Transfusion Reactions.
- Published: 2020-02-06
- Source: Episode page
One-liner
Episode 208 details six major transfusion reactions: AHTR (Type II, ABO error), Delayed Hemolysis (non-ABO antigens), Allergic (Type I, IgE crosslinking), FNHTR (cytokine release/Type III), TRALI (Anti-HLA complex deposition in lungs), TACO (fluid overload/cardiogenic edema), and TAGVHD (T-cell mediated attack).
High-yield summary
- Acute Hemolytic Transfusion Reaction (AHTR): Most common cause is ABO incompatibility (clerical error). Presents during transfusion with hematuria, flank pain. Mechanism: Type II hypersensitivity (preformed antibodies). Diagnosis: Direct Coombs Test positive.
- Allergic Reaction: Type I hypersensitivity. Triggered by transfused blood containing antigens to which the recipient has IgE antibodies. Presentation is predominantly airway/bronchospasm. Treatment requires immediate epinephrine.
- Febrile Non-Hemolytic Transfusion Reaction (FNHTR): Can be due to cytokine release from stored platelets/WB Cs (easy mechanism) or Type III hypersensitivity (recipient Ab attacking donor WB Cs, hard mechanism). Management: Antipyretics.
- TRALI: Non-cardiogenic pulmonary edema. Mechanism: Donor anti-HLA antibodies react with recipient leukocytes -> immune complex deposition in the lungs. Labs: PCWP < 18 mm Hg. Treatment: Supportive care; avoid diuretics.
- TACO: Cardiogenic pulmonary edema due to fluid overload from large volume transfusion. Mechanism: Heart failure exacerbation. Labs: PCWP > 18 mm Hg, elevated CVP/BNP. Management: Diuretics (e.g., furosemide).
- TAGVHD: T-cell mediated attack by donor T cells against recipient tissues. Risk factor: Immunocompromised recipient (e.g., post-BMT). Prevention: Gamma globulin administration or blood irradiation.
Learning objectives
- Differentiate between Type I, II, and III hypersensitivity reactions in the context of blood transfusion.
- Recognize the classic clinical presentation and underlying pathophysiology of AHTR vs. Delayed Hemolysis.
- Distinguish the pulmonary edema patterns (cardiogenic TACO vs. non-cardiogenic TRALI) using hemodynamic parameters (PCWP).
- Understand the mechanism and prevention strategies for T-cell mediated graft versus host disease (TAGVHD).
- Initiate appropriate supportive care, including fluid management and anti-inflammatory agents, based on the specific transfusion reaction.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Acute Hemolytic Transfusion Reaction (AHTR) | Flank pain, hematuria, fever; Direct Coombs positive | ABO incompatibility; Type II Hypersensitivity | Remember the timing: during transfusion. |
| TRALI | Non-cardiogenic pulmonary edema; PCWP < 18 mm Hg | Anti-HLA/Anti-WBC antibodies in donor blood; Type III Hypersensitivity | The low PCWP is critical for differentiating it from TACO. |
| TACO | Cardiogenic pulmonary edema; PCWP > 18 mm Hg; Elevated BNP | Fluid overload; Heart failure exacerbation | Treat with diuretics and fluid restriction, unlike TRALI. |
| Allergic Reaction | Bronchospasm, wheezing; IgE cross-linking | Transfused blood antigens; Type I Hypersensitivity | Immediate treatment requires epinephrine/antihistamines. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| AHTR | Hemolysis due to preformed antibodies (Type II) | ABO incompatibility, clerical error | High yield; always think of the timing and direct Coombs test. |
| TRALI vs TACO | TRALI: Low PCWP (<18); Non-cardiogenic edema. TACO: High PCWP (>18); Cardiogenic edema. | Transfusion complications; Hemodynamics | The most common trap question in this topic; focus on the pressure gradient. |
| Allergic Reaction | IgE crosslinking -> Mast cell degranulation (Type I) | Transfused blood antigens, mast cells | Requires immediate epinephrine administration for severe symptoms. |
| TAGVHD | T-cell mediated attack by donor cells on recipient tissues. | Immunocompromised patients (e.g., post-BMT); Donor T cells | Prevention involves gamma globulin or irradiation of the product. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient develops fever, chills, and flank pain shortly after receiving an incompatible blood transfusion (Type O recipient receives Type A). | Acute Hemolytic Transfusion Reaction (AHTR) | The timing (during the transfusion) and symptoms (flank pain/hematuria) are classic for acute intravascular hemolysis due to ABO incompatibility. |
| A patient with a history of multiple transfusions develops refractory hypoxemia, pulmonary infiltrates, and normal chest X-ray findings, but has a PCWP of 12 mm Hg. | Transfusion Related Acute Lung Injury (TRALI) | Non-cardiogenic edema (normal CXR/low PCWP) combined with transfusion risk points to TRALI. The low PCWP rules out TACO. |
| A patient receiving massive blood product transfusions, who has pre-existing heart failure and elevated BNP, develops bilateral crackles and pulmonary congestion. | Transfusion Associated Circulatory Overload (TACO) | This is a fluid overload state leading to cardiogenic edema. The high BNP and the clinical picture point to volume excess, not immune complex deposition. |
| A patient who recently underwent bone marrow transplantation develops fever, rash, and pancytopenia following transfusions; prophylaxis with gamma globulin was initiated. | Transfusion Associated Graft Versus Host Disease (TAGVHD) | This is a T-cell mediated rejection syndrome that occurs in immunocompromised hosts post-transplant. Gamma globulin prevents the donor T cells from attacking the recipient. |
| A patient develops wheezing and bronchospasm hours after receiving blood products, and their IgE levels are elevated. | Allergic Transfusion Reaction (Type I) | The hallmark of Type I hypersensitivity is mast cell degranulation mediated by IgE cross-linking, leading to acute airway symptoms. |
| A patient with a history of multiple transfusions develops fever days after the transfusion; the direct Coombs test is positive, but ABO incompatibility was ruled out. | Delayed Hemolytic Transfusion Reaction | The key differentiator is the timing (days later) and the non-ABO cause (e.g., Kidd or Kell antigens). |
Differential diagnosis / distinguishing features
TRALI vs TACO
| Key Features | Distinguishing Findings | Next Step |
| TRALI: Pulmonary edema is non-cardiogenic; low PCWP (<18 mm Hg). | TACO: Pulmonary edema is cardiogenic; high PCWP (>18 mm Hg). | If suspicion of TRALI, administer supportive care and avoid diuretics. |
| Pathophysiology: Immune complex deposition in the lungs (Type III). | Pathophysiology: Fluid overload/Heart failure exacerbation. | Monitor CVP and BNP levels to confirm fluid status. |
Management pearls
- AHTR: Aggressive IV fluid resuscitation is paramount to prevent acute tubular necrosis (ATN) from intravascular hemolysis.
- Allergic Reaction: Always treat severe reactions as anaphylaxis, regardless of initial stability; administer epinephrine promptly.
- TRALI: The primary treatment is supportive care and oxygenation; diuretics are contraindicated because they can worsen hypoxemia by reducing preload too much.
- TAGVHD: Prevention involves using gamma globulin or irradiating the blood product to neutralize donor T cells.
Don't miss
Integration & clinical reasoning
- Immunology Integration: Transfusion reactions are excellent examples of how preformed antibodies (Type II), IgE crosslinking (Type I), and circulating immune complexes (Type III) manifest in clinical practice, reinforcing fundamental immunology principles.
- Nephrology/Pulmonary Connection: The mechanism of TRALI—immune complex deposition leading to capillary leak syndrome—is analogous to the pathophysiology seen in certain nephrotic or vasculitic syndromes where immune complexes deposit in organs.
OMM / COMLEX integration
- For any patient presenting with acute respiratory failure (ARDS), standard emergency management (mechanical ventilation, oxygenation) takes priority over OMT.
- When managing suspected TACO/fluid overload, aggressive diuresis is appropriate and necessary to reduce pulmonary congestion; this contrasts sharply with the supportive care required for TRALI.
Concept connections / cross-references
- For a deeper dive into general transfusion medicine and blood typing, review [ Episode 102 ].
- Understanding Type I/II/III hypersensitivity is foundational; see detailed reviews on immunology in [ Episode 57 ].
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| AHTR | ABO incompatibility (Type O -> A/B) | Preformed IgM antibodies attacking transfused RB Cs. | Requires immediate cessation of transfusion and aggressive fluid resuscitation. |
| TRALI | Anti-HLA or anti-WBC antibodies in donor blood. | Immune complex deposition in pulmonary capillaries; Type III hypersensitivity. | Leads to non-cardiogenic pulmonary edema, mimicking ARDS. |
| TACO | Large volume transfusion + Heart failure risk factors. | Fluid overload leading to elevated filling pressures (PCWP > 18). | Requires careful diuresis and fluid restriction to manage congestion. |
| Allergic Reaction | IgE cross-linking on mast cells/basophils. | Transfused antigens reacting with recipient IgE. | The primary life threat is bronchospasm, requiring epinephrine. |
Key terms glossary
| Term | Definition | Context | Example |
| Type I Hypersensitivity | Immediate reaction mediated by IgE binding to mast cells/basophils. | Allergic reactions (e.g., transfusion, insect sting). | Bronchospasm and flushing due to histamine release. |
| Direct Coombs Test | Detects antibodies bound directly to the surface of red blood cells. | Diagnosis of hemolytic anemia or AHTR. | Positive result strongly suggests an immune-mediated hemolytic process. |
| PCWP (Pulmonary Capillary Wedge Pressure) | Measures left atrial filling pressure; surrogate for pulmonary venous pressure. | Differentiating cardiogenic vs. non-cardiogenic edema. | Low PCWP (<18 mm Hg) favors TRALI; High PCWP (>18 mm Hg) favors TACO. |
| Gamma Globulin | Immunoglobulin product used to neutralize T cells or prevent antibody formation. | Prevention of TAGVHD in immunocompromised patients. | Administering it before transfusion helps mitigate the risk of donor T-cell attack. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Hemolytic Reactions | Focus on timing (acute vs delayed) and mechanism (Type II). | High | Review blood bank protocols; practice differentiating AHTR from other causes of hemolysis. |
| Pulmonary Edema Syndromes | Create a flow chart comparing TRALI, TACO, and ARDS based on PCWP and etiology. | Critical | Memorize the specific lab thresholds (PCWP < 18 vs > 18) for differentiation. |
| Immune Mechanisms | Review Type I, II, and III hypersensitivity reactions using clinical examples. | Medium-High | Use mnemonic devices to recall key triggers (e.g., IgE -> Allergic; Immune Complex -> TRALI). |
Question pattern recognition
- Mechanism Identification: Given a clinical scenario (e.g., fever post-transfusion), identify the underlying immunological mechanism (Type I, II, or III).
- Differential Diagnosis: Distinguishing between two similar but distinct conditions (e.g., TACO vs. TRALI) based on specific lab values and physical exam findings.
- Prevention/Management: Knowing the prophylactic measure (e.g., gamma globulin for TAGVHD) or immediate life-saving treatment (e.g., epinephrine for anaphylaxis).
Test yourself
Common mistakes to avoid
Common traps
Original transcript with highlights
Original transcript with highlights
Okay, welcome. My name is Divine, I'm a resident. This is episode 208 of the Divine Intervention Podcast. And in this podcast, this is going to actually be a short one. I'm going to be talking about transfusion reactions. This is a concept that I am pretty certain of disgusting some other podcasting bits and pieces before. What I just want to have one specifically dedicated to these are reactions because these things are commonly tested on exams. And I feel like I've both treated people recently and just heard from people, many people getting this kind of stuff wrong because they mean they love to test it because it's somewhat confusing and people do not pay much attention to it. So let's just jump right into it. So there are multiple types of transfusion reactions, right? Like there is the acute hemolytic transmission reaction, there is the delayed hemolytic transmission reaction, there is the allergic transmission reaction, there is the fibromone hemolytic transmission reaction, there is something called traly, transmission related acute lung injury, there's something called taco, transmission associated circulatory overload, right? So those are the six major ones that tend to be tested on the USML Es and over the next few minutes I'm going to break those down, explain to you how exactly how they present for an exam so that you can know exactly how they are managed.
So basically the first one, the acute hemolytic transmission reaction, basically the most common cause of this is abu incompatibility. Essentially the thing that happens on MBME exam is these people, right? Let's say for example you're getting type, let's say you're a type O blood person, right? So you have type O blood. So that means you'll have antibodies against the A and T gene and the B antigen, right? So if you've got for a bit for some reason you get A blood or B blood, right? You already have preformed antibodies against those antigen. You get that blood transfusion immediately, you start having hemolysis of those red blood cells with those preformed antibodies and that can cause some pretty significant problems, right? And the most common cause again like I said, a clerical errors, that's a high-oven you want to keep at the back of your mind for these exams. So acute hemolytic transmission reaction, how will you present for an exam? Again, it would be like during the transmission, the patient will start having hematuria, right? The patient will start complying of back pain or flunk pain. So if you see a person during the course of a transmission, complying of flunk pain or back pain and like hematuria, think about an acute hemolytic transmission reaction. And your diagnostic test on an MBME exam is to go ahead and consider performing a direct comp test, okay? A direct comp test. A direct comp test is very, is essentially really diagnostic for for this, right?
And remember that this is actually an example of a type two hypersensitivity reaction, okay? It's an example of a type two hypersensitivity reaction because you have preformed antibodies again, hemolyzing those red blood cells. Those are examples of tides, an example of a type two hypersensitivity reaction. And really in terms of treatment, really what you typically do is you give a ton of fluid, right? By giving that fluid all that hemolysis of red blood cells, so it doesn't gunk up the kidneys and cause like acute tubular macrosis or like an intra-inertic GI. Essentially the thing that happens is that you, you know, you give a ton of fluid, you know, it's almost like the way you filter out the miles is in a sense, right? So you kind of like flush away all that badness. Sometimes people that have these acute hemolytic transmission reactions, they go into DIC. Under those circumstances, you know, you want to give them like platelets, you want to give them like cryoprecipitate, you want to give them FFP. But other than that, that's pretty much how you manage, that's pretty much how you manage those disorders, right? So again, the most common cause is a clerical error. Again, that's something absolutely wants to come into memory. And again, red urine, right? So hematuria, like hemoglobinuria, right? And you have flunk pain. That's what you're looking for on an in-be-mixer. Now, a delayed hemolytic transmission reaction.
Basically, the pathophysiology is essentially the same thing as an acute hemolytic transmission reaction. But the reaction does not, the key difference is that the reaction does not occur during the transmission. It would usually occur like days after the transmission has happened. That's the classic thing that you tend to put on in-be-mixers, okay? So the problem arises days after the transmission has happened. And they will typically in that case, they give you like a cum stress result and you will actually notice that you'll be positive, right? So those people will have a positive direct cum stress, but they will have again a hemolytic episode days after the transmission happened. And the key critical thing there is that those people tend to have much less severe reactions. They didn't have much less severe reactions, right? So they usually do not, you know, it's not something that requires like organbusters, ribbons or anything like that. The reactions are usually pretty, pretty, pretty mild, right? So it's also a kind of type two hypersensitivity reaction. And again, it happens days after the transmission happens. And usually it typically does not arise because of ebueing compatibility. It almost always arises because of some other kind of antigen like the kid antigen like the GI, double the antigen or the, sometimes you can see like the Kell antigen or the doffy antigen. Those are kind of like the big things there.
So that's all I think I'm going to say about the late hemolytic transmission reaction. Now, the next one I think I want to jump to is the allergic transmission reaction. This classically shows open MB Ms in the context of a pressing that has IG deficiency. Essentially, the thing that happens is you, you get a blood transfusion and when you get a blood transfusion, they ask you that, that transfused blood contains things that you have IGE antibodies against, right? Contains things you have IGE antibodies against. So if you take that transfused blood, you take those antigens from those antigens, you know, they will react with IGE. You have cross-linking of the, you have cross-linking of the, of the IG Es on the surfaces of mast cells, right? When you release those nasty things like histamine and heparin and all that stuff and that can cause bronchospasem and cause pretty significant problems, right? So those people, the classic presentation, the airway problems, okay? They will have predominantly airway problems, right? So they'll have like bronchospasem, they'll have wheezing, right?
They'll have like an anaphylactic stout presentation and typically the thing you do for those people, I mean if it's a mild reaction, if like they're satin-fine, their blood pressure is fine and everything, you can go ahead and give those people an antihistamine and then you know, if they kind of get better, you can then resume the reaction, but if it's like a severe reaction, which I would say for the most part, you should maybe expect more on an in-beam exam. You want to go ahead and give those people IMEP in effort because it's literally an anaphylactic reaction, right? And because it's an anaphylactic reaction or you can say an allergic reaction, essentially the thing that's happening with those foxes is it's, it's actually a type one hypersensitivity reaction. That's one thing the in-beam kind of expect you to know, it's a type one hypersensitivity reaction and think about it, right? Think about this. People that are IgE deficient, right? If they IgE is a foreign local to them, right? So if for example they get transfused blood and that transfused blood contains IgE, right? Then they probably have like IgE antibodies because remember, you know when you get exposed to an allergic or an antigen the first time the first antibody you make is IgM, but after you make IgM there is such a thing as claspswiching, right? And claspswiching, especially if you're looking using interlooking four, you can claspswich to IgG and IgE.
Or if you have interlooking five you can claspswich to IgE, right? So the thing is if you make IgE antibodies then you begin to get into trouble, right? And you can get those kinds of problems. And again because it's an anaphylactic reaction, for the most part you need to strongly consider putting those people on an IMA pinnephrase, right? So that they don't pass away. Now the next one I want to talk about, I want to talk about the febrile non-hebolytic transition reaction, okay? The febrile non-hebolytic transition reaction. Essentially the febrile non-hebolytic transition reaction pretty much can arise by the way it will present is typically will be a person that during the course of a blood transfusion they develop like fevers, right? But you know they'll be febrile, they may have like a mild tacky cardia, but they won't really have significant hemodynamic instability, okay? They won't really have significant hemodynamic instability. And one key thing to keep at the back of your mind with these are febrile reactions, right? Is again either during the transfusion or you know around like one to four hours after the transfusion is over, okay? That's one thing you absolutely want to keep at the back of your mind on exams, right?
And the thing is this is actually one of those things where understanding the mechanism is very useful for purposes of the NV Me exams because the thing is your friends at the NV Me they begin to write these questions where they demand mechanistic reasoning, especially on step two CK. I mean step one they've been doing it all along, right? But step two CK, right? So one thing I will definitely say is it's probably not the worst idea in the world to understand this. And the reason that I'm going to emphasize the mechanism here today is that there are some very nice parallels with the mechanism behind another kind of transfusion reaction called trolley. Transfusion released it acute lung injury, right? So let's go ahead and break that down and talk about things, right? So the thing is when a person has a febrile monhemolytic transfusion reaction, the thing that happens is they are one of two mechanisms. Let me talk about the easy mechanism and then I'll talk about the hard mechanism. The easy mechanism, which is the first one, essentially revolves around the fact that when you have blood elements, right? Especially platelets, platelets are probably one of the big ones that tend to cause this kind of problem, right? Blood, when you know, you have blood stored in the blood bank, it can actually contain white blood cells and those white blood cells, right? Especially again, the reason I'm saying it's platelets is white blood cells, they survive very well at room temperature.
The thing is platelets tend to generally be stored at room temperature, most other blood elements and not stored at room temperature. So the thing that happens is if you have platelets, you know, you get a platelet transfusion and then from those platelet transfusions, you, you, those white blood cells that have been sitting in the blood bank, you know, they are still active, they are still able to make cytokines, those cytokines, right? Can, you know, activate, like, you know, cause fever and all that stuff, right? So you know, the person will have like fever, chill, some maltaqi cardio, nothing serious there. All you need to do for these people is just give them something that reduces fever like, you can give like a set of minofin, for example, right? And again, these transfusion reactions, I promise you like on many shelf exams, like surgery, medicine, peds, they love to test all this stuff. So this is something you absolutely want to make sure you understand and keep at the back of your mind, for example, it's just something that they love, love, love, love, love to test all the time on tests. So that's the easy mechanism. The heart mechanism is that for a febrile non-hymolytic transfusion reaction, the thing that happens is you can have antibodies. So the person rate, the recipient of the blood transfusion, right? The recipient has antibodies and those antibodies, they can attack white blood cells that are present.
They can attack white blood cells that are present on the in the blood that's been transfused, right? And basically the thing that happens is you essentially form an antigen antibody complex. So this is actually an example of a type three hypersensitivity reaction. So you form an antigen antibody complex. And the thing is when those antibodies, right, from the from the recipient bind to the antigens, which are the leukocytes of the donor blood, right? You then have a release of cytokines and then that causes all those problems, right? So the reason I'm being very specific here is that in a febrile non-hymolytic transfusion reaction, I'm saying that the antibodies come from the recipient and then the antigens on the white blood cells are in the donor blood. That is very different from what obtains in trily transfusion relief rate acute lung injury, okay? You have the antibodies coming from the donor blood and then you have the affected leukocytes coming from the recipient's blood, okay? So that's something you absolutely want to keep at the back of your mind, for example, right? So I guess with that said, let me just maybe go ahead and jump to the transfusion related acute lung injury. The easy way to understand transfusion related acute lung injuries, this is essentially ARDS in a person that gets a blood transfusion. That is literally the easiest way to think about this. It's ARDS in a person that gets a blood transfusion. And again, I essentially already explained, right?
You have antibodies in the donor blood attacking white blood cells in the recipient blood. And when you have that, again, antigen antibody complex come together. So again, that'll be an example of a type three hypersensitivity reaction. You can release things like histamine, for example, you can release really kind, you can release leukotrines. Remember, those things, especially, especially if you have like an antigen, one antigen antibody complex that has a greater affinity for the lung parankoma, those things can settle there. And all that inflammation that then happens will subsequently cause like long damage. You'll increase pulmonary vasculopremability and you have essentially like a non-cardiogenic pulmonary dima. In fact, I can envision your friends at the MBM, right in a question where they give you a pulmonary capillary which preserves a person that has trally. And obviously that pulmonary capillary which preserves will be normal. You'll be less than the magic number of 18, okay? You'll be less than the magic number of 18, right? Because the person has a non-cardiogenic pulmonary dima. That is something you absolutely want to commit to memory for your exams, okay? Now, the thing is, you may see it divine. Can you maybe give me an analogy that may help you understand this? The thing is, think about it. Think about it. When a person has like one of these nephrodic and ephrodic syndrome, so we all know that it arises from antigen-antibody complexes.
Those antigen-antibody complexes, they go to the kidneys. You know, like some people that you know just when they come to a place, trouble comes with them, right? It's kind of like the same thing. You have these antigen-antibody complex, they are like, oh, they may have been from somewhere completely different. And then they say, oh, you know, let's come to the kidney. Maybe because they have like very good affinity for some kidney antigens, they come there and they trigger chaos and then they destroy the kidneys, right? So I almost think of trally. Like if you really dig down to the pathophysiology, the pathophysiology is almost identical to what happens in the kidneys. It's almost like like one of those nephrodic and ephrodic syndromes, but it happens in the lungs because those antigens and antibodies, the antigen-antibody complexes settle in the lungs instead of settling in the kidneys, okay? So that's the mechanism. That's the pathophysiology behind transfusion related acute lung injury, okay? Transfusion related acute lung injury. That's again, that's a high-youth thing to know. And again, it's essentially like ARDS. So essentially what you want to do for these people is you know, you want to give them like pulmonary support. Trial, it has a pretty high mortality, you know, just, you know, pulmonary support is going to be placed on vents. You can give them like, if they have high potency, if you can give them fluids, you can give them pressures.
It's actually very high-youth remember that you don't want to give these people diuretics. Diuretics are a terrible idea in a person that in a person that has a transfusion related acute lung injury. In some cases, you could also give these people clinical steroids. So just kind of know those different treatments for travi. Now, the other transfusion related reaction I think I want to talk about is taco, right? So transfusion associated a secretary overload. Basically, this one is almost like, this one is essentially like a person that has like risk factors for like, you know, like bad hearts, you know, like heart failure, blah, blah, blah, blah, blah, you give them like a large volume blood transfusion, right? And then they subsequently get into trouble because their hearts cannot handle the fluid. So because your hearts cannot handle the fluid, most of that fluid, the blood from the large volume transfusion kind of backs up in the lungs. And if you backs up in the lungs, that's a problem, right? Because that was cause-pobonary dima. But unlike Charlie, which I said was a non-cardiogenic pomonary dima taco is a cardiogenic pomonary dima, okay? So in this circumstance, the pomonary capillary which pressure will be greater than the magic number of 18. And because this is essentially almost like a fluid overload, right? Then treatment will, it would make sense that giving diuretics helps significantly on that these are circumstances.
And one other thing that your friends at the end in me do to, you know, mildly mess with your head is, if a person has a taco, right? Like they may give you like a B and they can give you, I can just imagine them giving you like a chart with arrows. And then they put like the PCWP in one hour, they put like the central venous pressure in one hour, they put like the BMP writing one hour. And all those things will go up, right? Remember the CVP is a proxy for right? It's your pressure. You will go up because there's fluid overload in the hearts. The heart cannot come that lot forward, right? And then the PCWP, which is a surrogate for left H.O. pressure will also be increased, right? And obviously, right, the presence BMP will be increased because remember whenever the chambers of the H.R. or the ventricles are distended with fluid, right? Especially like on a chronic basis, they tend to release a ton of, they tend to release a ton of AMP and BMP to try to counter those effects, basically like to almost like shut down the activity of the reading and the testing on the student system. So you can get rid of that excess of that excess fluid. So that's the pathophysiology and that's the treatment for for taco, right? Now, another thing I want to talk about in terms of, um, um, transmission reactions, right? So there's this thing known as a transmission associated graft versus host disease. Transfusion associated graft versus host disease, I mean, it's very bad.
The mortality is, uh, the mortality is terrible. Basically, the thing that happens is that you have T cells in the donor blood, they begin to attack, like T-shoe in the recipe, like in the recipe, right? That's obviously like super, super, super, super bad, right? That is super, super, super bad. I mean, if I'm long-nesticking, the mortality for this is like 90% or like some really high, I'm pretty sure it's at least 90%. Right? So it's pretty bad, right? And usually the risk factor is the recipe, it may be like an immunocompromised person, maybe this person recently got like a like a bone marrow transplant or something like that. And typically those people, you know, after they get the transmission, they'll begin to have fevers, they'll have like a rash. Sometimes they can have like big liver, right? So they have like a pato megalith, they can have diarrhea, they can have like a panside opine, like all the, like their white blood cell, count red blood cell, completely count everything will be low. Just, you know, just badness all around, just badness, badness, badness all around. And you may say, okay, how do you prevent this? Well, the way you prevent this is you use gamma risk to essentially irreduce the person's blood. I mean, it radiates the donor blood, right? So that you don't get into those problems so that the T cells are killed and destroyed. I mean, basically on an MDM exam, you want to think twice and better know what you're doing.
And also in the real world, before giving blood transfusions to immunocompromised patients, because things like this can happen. And again, transfigure and associated graft versus host disease, there's literally no treatment. The person is almost certainly going to die, right? So you just want to keep those things at the back of your mind. And then one thing I think I want to mention is this whole idea of a local reduction. Local reduction is basically where you try to reduce the number of white blood cells in a donor blood sample. That thing can actually help quite significantly with, with a graft, I mean, not with the fibromonti-molelic transition reaction, because essentially getting rid of the white blood cells that can produce those cytokines and give rise to trouble, right? And local reduction, right? It's also, again, something you can do, something you can do if a mum is speaking, also in people that have had like allergic transfusion reactions, but that I'm not 100% sure of how I'd encourage you to look that up, but I'm fairly setting that issue. So I think I've pretty much discussed all the major high-yield ones. So I think I'm going to go ahead and pause here. As I do at the end of every podcast, I do offer one on one tutoring for many exams and also a large group tutoring for the USM list, step one, step two CK, step three, step two CS exams, pre-clinical medical exams, right? Third year shelf exams, basically all the shelf exams I tutor for.
And then if you're a college student applying to med school, so like an ERAS application, I mean an AMCA application or a med student applying to residency, so like an ERAS application I do offer, again like one on one coaching with like rec letters, personal editing, personal statements, editing applications, doing work interviews. Again, I've worked with tons of people and the vast majority of people have worked with, have all much that they are first choice. And then I offer these booster courses for step one, step two CK and step three, where it's 15 hours for step two CK and step three and it's 10 hour, I mean it's 20 hours for step one. And the long and short of things is I essentially review the most known the high yields for those exams in a very short time frame. I meet with the Tuti over a couple of sessions. And again, many people that have done that with a founded to be extremely helpful. And so if you need details on email these things, just reach out to me that through the website or you can send me an email, divine intervention podcasts with an sdn.gmail.com. Right? And then if you know, no, a college body that needs to bring from a general chemistry, organic chemistry, physics, biochemistry, histology, physiology, again, I do offer one on one tutoring for all those students. So have a wonderful night rest. Thank you for listening to this podcast. Please subscribe to the website. Please subscribe.
I mean, I have this podcast now on Apple podcasts on Spotify and Google Play. And also I do have a You Tube channel is called Divine Intervention Podcasts and videos. So please subscribe. Any positive comment, any feedback helps. So I would really beg if you could. And I would God willing continue to make these wonderful podcasts and videos. So have a wonderful rest of your night. God bless you. I'll see you in the next podcast. Thank you.
Practice questions — USMLE style
Question 1 — Hematology/Immunology
A 45-year-old male receives an emergency blood transfusion due to massive hemorrhage. Shortly after the transfusion begins, he develops flank pain, fever, and dark red urine. Laboratory studies reveal significant hemoglobinuria. The most likely underlying cause is ABO incompatibility resulting from a clerical error in the blood bank. Which type of hypersensitivity reaction best describes the pathophysiology of this acute hemolytic episode?
- A) Type I hypersensitivity due to IgE cross-linking
- B) Type II hypersensitivity involving preformed antibodies
- C) Type III hypersensitivity mediated by complement activation
- D) Delayed-type hypersensitivity requiring T-cell mediation
Answer: B. The patient is experiencing an Acute Hemolytic Transfusion Reaction (AHTR). This reaction occurs because the recipient possesses preformed IgM or IgG antibodies against donor antigens (e.g., anti-A, anti-B). These antibodies immediately bind to the transfused red blood cells, leading to rapid intravascular hemolysis. This mechanism—antibody binding and subsequent cell destruction—is characteristic of a Type II hypersensitivity reaction.
Question 2 — Critical Care/Cardiology
A 70-year-old patient with known chronic heart failure receives a large volume blood transfusion in the operating room. Shortly after, he develops acute respiratory distress syndrome (ARDS) characterized by bilateral pulmonary infiltrates and severe hypoxemia. Physical examination reveals signs of fluid overload, including elevated jugular venous pressure (JVP). Which statement accurately differentiates this condition from Transfusion-Related Acute Lung Injury (TRALI)?
- A) TRALI is typically associated with a low pulmonary capillary wedge pressure (PCWP < 18 mm Hg), whereas TACO presents with high PCWP.
- B) The primary mechanism of TACO involves the release of cytokines from donor platelets, while TRALI involves antibody-antigen complex deposition.
- C) In TACO, the pulmonary edema is non-cardiogenic because it results from systemic inflammatory mediators.
- D) Both conditions are treated identically with aggressive diuresis and fluid restriction to manage volume overload.
Answer: A. Transfusion Associated Circulatory Overload (TACO) occurs in patients who have pre-existing cardiac compromise, leading to cardiogenic pulmonary edema. This condition is characterized by elevated filling pressures, meaning the PCWP will be high (> 18 mm Hg). Conversely, TRALI causes non-cardiogenic pulmonary edema due to endothelial damage and inflammation, resulting in normal or low pulmonary capillary wedge pressure (< 18 mm Hg).
Question 3 — Allergy/Immunology
A patient with a history of IgE deficiency undergoes a blood transfusion. Shortly after the transfusion, they develop severe bronchospasm, wheezing, and hypotension requiring immediate epinephrine administration. The underlying mechanism involves donor antigens cross-linking recipient IgE antibodies fixed on mast cells. This clinical presentation is characteristic of which type of hypersensitivity reaction?
- A) Type II hypersensitivity
- B) Type III hypersensitivity
- C) Type I hypersensitivity
- D) Delayed-type hypersensitivity
Answer: C. The symptoms (bronchospasm, wheezing, hypotension) and the mechanism described—antigen cross-linking IgE on mast cells leading to mediator release (histamine)—are classic hallmarks of a Type I immediate hypersensitivity reaction. This is an anaphylactic process. Management requires epinephrine due to the life-threatening nature of this type of reaction.
Question 4 — Hematology/Transfusion Medicine
A patient who recently underwent a bone marrow transplant and has profound neutropenia receives multiple blood transfusions. Days after transfusion, the patient develops fever, rash, diarrhea, and pancytopenia. The most likely diagnosis is Transfusion-Associated Graft Versus Host Disease (TA-GVHD). What is the primary method used to prevent this severe complication during blood product preparation?
- A) Administering high doses of corticosteroids to suppress T-cell activity.
- B) Performing leukoreduction to remove white blood cells from donor products.
- C) Utilizing gamma globulin reduction to neutralize circulating antibodies.
- D) Providing prophylactic antibiotics and antifungals due to neutropenia.
Answer: C. TA-GVHD occurs when donor T lymphocytes recognize the recipient's tissues (e.g., gut mucosa, skin) as foreign, leading to a severe immune attack. The primary prevention strategy is using gamma globulin reduction on the donor blood product. This process effectively removes or inactivates the circulating T cells, thereby preventing the graft versus host reaction.
Quick fire review
What is the most common cause of Acute Hemolytic Transfusion Reaction (AHTR)?
Clerical error, specifically ABO incompatibility.
How does the timing differentiate AHTR from DHTR?
AHTR occurs immediately/during transfusion; DHTR occurs days after transfusion.
What type of hypersensitivity reaction is an allergic transfusion reaction (ATR)?
Type I Hypersensitivity (IgE mediated).
Which condition presents with a low PCWP (<18 mm Hg) and non-cardiogenic pulmonary edema?
Transfusion Related Acute Lung Injury (TRALI).
What distinguishes TACO from TRALI regarding pulmonary capillary wedge pressure (PCWP)?
TACO has elevated PCWP (>18 mm Hg); TRALI has normal/low PCWP.
What is the primary mechanism of injury in a Febrile Non-Hemolytic Transfusion Reaction (FNHTR) with platelets?
Cytokine release from stored white blood cells activated by platelet transfusions, causing fever.
Mechanism and type of hypersensitivity for AHTR?
Type II Hypersensitivity; preformed antibodies attack donor RB Cs.
Key diagnostic finding for DHTR?
Positive Indirect Coombs Test (IAT) days after transfusion.
What is the primary treatment for severe allergic/anaphylactic transfusion reaction?
Intramuscular Epinephrine (IM Epi).
Which type of pulmonary edema involves donor antibodies attacking recipient WB Cs, and requires supportive care but NO diuretics?
TRALI (Transfusion Related Acute Lung Injury).
What is the key preventative measure against Transfusion Associated Graft Versus Host Disease (TAGVHD)?
Using Gamma globulin to inactivate T cells.
If a patient has TACO, what are the expected findings for PCWP and CVP?
Both will be elevated (>18 mm Hg) due to fluid overload/heart failure.
Quick recall / Anki-style questions
Mechanism and type of hypersensitivity for AHTR?
Type II Hypersensitivity; preformed antibodies attack donor RB Cs.
Key diagnostic finding for DHTR?
Positive Indirect Coombs Test (IAT) days after transfusion.
What is the primary treatment for severe allergic/anaphylactic transfusion reaction?
Intramuscular Epinephrine (IM Epi).
Which type of pulmonary edema involves donor antibodies attacking recipient WB Cs, and requires supportive care but NO diuretics?
TRALI (Transfusion Related Acute Lung Injury).
What is the key preventative measure against Transfusion Associated Graft Versus Host Disease (TAGVHD)?
Using Gamma globulin to inactivate T cells.
If a patient has TACO, what are the expected findings for PCWP and CVP?
Both will be elevated (>18 mm Hg) due to fluid overload/heart failure.